PATENT CLAIM ANALYSIS

Application Number: 15968241
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2019-01
Patent Classification: ["424", "204100"]

Abstract:
A vaccine vector comprising an attenuated, recombinant ranavirus that has at least one foreign expression element is disclosed. In other contemplated embodiments, a vaccine vector comprising a virus, wherein the virus is engineered to express at least two vaccine antigens is disclosed. In addition, methods of delivering human antigens to a mammal are disclosed that include: providing a non-mammalian virus, engineering a recombinant virus that can express at least one foreign molecule by modifying the non-mammalian virus, and using the recombinant ranavirus to deliver human antigens to a mammal.

Claim (Index 12):
The method of  claim 9 , wherein the at least one foreign molecule comprises at least one foreign protein, at least two vaccine antigens, at least one virus-like particle, or a combination thereof.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 93.0
- Lexical Diversity: 1.90385
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12293001', '11022477', '13983722', '12956949', '12090083']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7411359397143548
- 35 USC 102 Novelty (BERT): 0.4983884483552173
- Combined Prediction Score: 0.716861190578441
- Mean Citation Score: 221.618114
- Max Citation Score: 227.13087
- Similarity Product: 156.87095123255787

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test